NVIDIA Corporation vs. Universe Pharmaceuticals Inc. Class A Ordinary Shares
NVDA
NVIDIA Corporation
$222.27 +1.34%
VS UPCUniverse Pharmaceuticals Inc. Class A Ordinary Shares
$4.78 +0.42%
NVIDIA Corporation (NVDA) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| NVDA | UPC | |
|---|---|---|
| Market Cap | $5.30 trillion | $23.92 million |
| Revenue (TTM) | $302.97 billion | — |
| Net Income (TTM) | $192.88 billion | — |
NVDA leads on 1 of 1 size & scale factors.
Valuation
| NVDA | UPC | |
|---|---|---|
| P/E Ratio | 28.10 | — |
| Price / Book | 23.13 | — |
| Price / Sales | 17.48 | — |
NVDA and UPC split the valuation factors evenly.
Profitability
| NVDA | UPC | |
|---|---|---|
| Net Margin | 63.66% | — |
| Return on Equity | 84.23% | — |
NVDA and UPC split the profitability factors evenly.
Dividend
| NVDA | UPC | |
|---|---|---|
| Dividend Yield | 0.45% | — |
| Payout Ratio | 12.64 | — |
NVDA and UPC split the dividend factors evenly.
Risk & Sentiment
| NVDA | UPC | |
|---|---|---|
| Short Interest | 0.07% | 25.95% |
NVDA leads on 1 of 1 risk & sentiment factors.
Dig deeper: NVDA overview, NVDA financials, UPC overview, UPC financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.